South Korea
· Delayed Price · Currency is KRW Sewoon Medical Statistics
Total Valuation
Sewoon Medical has a market cap or net worth of KRW 111.47 billion. The enterprise value is 25.94 billion.
| Market Cap | 111.47B |
| Enterprise Value | 25.94B |
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
Sewoon Medical has 43.29 million shares outstanding. The number of shares has increased by 0.16% in one year.
| Current Share Class | 43.29M |
| Shares Outstanding | 43.29M |
| Shares Change (YoY) | +0.16% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 53.40% |
| Owned by Institutions (%) | 0.12% |
| Float | 20.17M |
Valuation Ratios
The trailing PE ratio is 10.02.
| PE Ratio | 10.02 |
| Forward PE | n/a |
| PS Ratio | 1.86 |
| PB Ratio | 0.75 |
| P/TBV Ratio | 0.77 |
| P/FCF Ratio | 10.96 |
| P/OCF Ratio | 9.44 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 1.86, with an EV/FCF ratio of 2.55.
| EV / Earnings | 2.33 |
| EV / Sales | 0.43 |
| EV / EBITDA | 1.86 |
| EV / EBIT | 2.47 |
| EV / FCF | 2.55 |
Financial Position
The company has a current ratio of 13.11, with a Debt / Equity ratio of 0.01.
| Current Ratio | 13.11 |
| Quick Ratio | 11.00 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.07 |
| Debt / FCF | 0.10 |
| Interest Coverage | 264.11 |
Financial Efficiency
Return on equity (ROE) is 7.98% and return on invested capital (ROIC) is 4.52%.
| Return on Equity (ROE) | 7.98% |
| Return on Assets (ROA) | 4.22% |
| Return on Invested Capital (ROIC) | 4.52% |
| Return on Capital Employed (ROCE) | 7.00% |
| Revenue Per Employee | 344.10M |
| Profits Per Employee | 64.00M |
| Employee Count | 174 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 2.10 |
Taxes
In the past 12 months, Sewoon Medical has paid 2.74 billion in taxes.
| Income Tax | 2.74B |
| Effective Tax Rate | 19.24% |
Stock Price Statistics
The stock price has decreased by -11.86% in the last 52 weeks. The beta is 1.28, so Sewoon Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.28 |
| 52-Week Price Change | -11.86% |
| 50-Day Moving Average | 2,432.40 |
| 200-Day Moving Average | 2,546.75 |
| Relative Strength Index (RSI) | 62.76 |
| Average Volume (20 Days) | 111,868 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sewoon Medical had revenue of KRW 59.87 billion and earned 11.14 billion in profits. Earnings per share was 256.95.
| Revenue | 59.87B |
| Gross Profit | 21.41B |
| Operating Income | 10.49B |
| Pretax Income | 14.22B |
| Net Income | 11.14B |
| EBITDA | 13.97B |
| EBIT | 10.49B |
| Earnings Per Share (EPS) | 256.95 |
Balance Sheet
The company has 89.54 billion in cash and 985.65 million in debt, giving a net cash position of 88.55 billion or 2,045.56 per share.
| Cash & Cash Equivalents | 89.54B |
| Total Debt | 985.65M |
| Net Cash | 88.55B |
| Net Cash Per Share | 2,045.56 |
| Equity (Book Value) | 149.10B |
| Book Value Per Share | 3,374.54 |
| Working Capital | 112.91B |
Cash Flow
In the last 12 months, operating cash flow was 11.81 billion and capital expenditures -1.63 billion, giving a free cash flow of 10.17 billion.
| Operating Cash Flow | 11.81B |
| Capital Expenditures | -1.63B |
| Free Cash Flow | 10.17B |
| FCF Per Share | 234.97 |
Margins
Gross margin is 35.76%, with operating and profit margins of 17.52% and 18.60%.
| Gross Margin | 35.76% |
| Operating Margin | 17.52% |
| Pretax Margin | 23.76% |
| Profit Margin | 18.60% |
| EBITDA Margin | 23.33% |
| EBIT Margin | 17.52% |
| FCF Margin | 16.99% |
Dividends & Yields
This stock pays an annual dividend of 60.00, which amounts to a dividend yield of 2.33%.
| Dividend Per Share | 60.00 |
| Dividend Yield | 2.33% |
| Dividend Growth (YoY) | -14.29% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 27.21% |
| Buyback Yield | -0.16% |
| Shareholder Yield | 2.18% |
| Earnings Yield | 9.99% |
| FCF Yield | 9.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 24, 2009. It was a forward split with a ratio of 2.
| Last Split Date | Sep 24, 2009 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Sewoon Medical has an Altman Z-Score of 9.59 and a Piotroski F-Score of 5.
| Altman Z-Score | 9.59 |
| Piotroski F-Score | 5 |